EAN 2020

Alzheimer's Disease and Other Dementias

Non-Alzheimer’s disease pathophysiology in the elderly

Expert

Prof. Philip Scheltens, Amsterdam UMC, the Netherlands

Conference

EAN 2020

8 September, 2020 10:58

Novel genetic association with resistance to ERC tau deposition

Expert

Vijay K Ramanan, Mayo Clinic–Rochester, Minnesota, USA

Conference

EAN 2020

8 September, 2020 10:55

News on AD biomarkers

Conference

EAN 2020

8 September, 2020 10:50

Diastolic dysfunction novel risk factor for cognitive impairment

Expert

Dr A. Parker, Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, USA

Conference

EAN 2020

8 September, 2020 10:08

Epilepsy

Avoidable epilepsy-related mortality remains high

Presented By

Mr Gashirai K Mbizvo, The University of Edinburgh

Conference

EAN 2020

9 September, 2020 15:09

How genetic testing can contribute to epilepsy management

Presented By

Dr Guido Rubboli, University of Copenhagen, Denmark

Conference

EAN 2020

9 September, 2020 15:08

Cenobamate effective in focal epilepsy

Presented By

Prof. Bernhard J. Steinhoff, Kork Epilepsy Center, Germany

Trial

Phase 2, C013, C017

Conference

EAN 2020

9 September, 2020 15:06

Sustained seizure reductions with cannabidiol for Lennox-Gastaut syndrome

Presented By

Dr Anup D. Patel, Nationwide Children’s Hospital, OH, USA

Trial

Phase 3, GWPCARE

Conference

EAN 2020

9 September, 2020 14:59

Prevalence of autoantibodies in epilepsy almost 10%

Presented By

Dr Ronan McGinty, University of Oxford, UK

Conference

EAN 2020

9 September, 2020 14:54

Parkinson's Disease

Stroke

Benefits of statins to prevent stroke outweigh risks

Presented By

Dr Ammad Ishfaq, Zeenat Qureshi Stroke Institute, USA

Conference

EAN 2020

9 September, 2020 16:30

Extubation after thrombectomy: the sooner, the better

Presented By

Dr Simon Fandler-Höfler, Medical University of Graz, Austria

Conference

EAN 2020

9 September, 2020 16:25

Thrombus location and length predictors of early neurological deterioration

Presented By

Dr Pierre Seners, Université Paris Descartes, France

Trial

MINOR-STROKE

Conference

EAN 2020

9 September, 2020 16:22

Endovascular treatment in large vessel occlusion stroke patients treated with OAC

Presented By

Mr Clemens Küpper, Ludwig-Maximilians-University of Munich, Germany

Trial

German Stroke Registry-Endovascular Treatment

Conference

EAN 2020

9 September, 2020 16:13

Early edoxaban may be safe after cardioembolic stroke

Presented By

Dr Giovanni Frisullo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma, Italy

Trial

SATES

Conference

EAN 2020

9 September, 2020 16:09

Headache and Pain

Small fibre pathology as biomarker for fibromyalgia

Presented By

Dr Dimitar Evdokimov, University of Würzburg, Germany

Conference

EAN 2020

10 September, 2020 11:10

Migraine as a cyclical functional disorder

Presented By

Mr Daniele Martinelli, University of Pavia, Italy

Conference

EAN 2020

10 September, 2020 11:07

Reassuring real-world safety profile of 3 CGRP inhibitors

Presented By

Prof. Stephen D. Silberstein, Thomas Jefferson University, PA, USA

Conference

EAN 2020

10 September, 2020 11:03

Long-term cardiovascular safety of erenumab

Presented By

Dr Stewart Tepper, Geisel School of Medicine, USA

Conference

EAN 2020

10 September, 2020 10:58

Real-world data for erenumab in Germany

Presented By

Prof. Andreas Straube, Ludwig-Maximilians-University Munich, Germany

Trial

TELESCOPE

Conference

EAN 2020

9 September, 2020 17:13

Eptinezumab in chronic migraine and medication-overuse headache

Presented By

Prof. Hans-Christoph Diener, Medical Faculty of the University Duisburg-Essen, Germany

Trial

Phase 3, PROMISE-2

Conference

EAN 2020

9 September, 2020 17:09

Fremanezumab tolerability in cardiovascular patients with migraine

Presented By

Dr Gianluca Coppola, Sapienza University of Rome, Italy

Trial

Phase 3, HALO, FOCUS

Conference

EAN 2020

9 September, 2020 17:05

Effects of galcanezumab on health-related quality of life

Presented By

Dr Stewart Tepper, Geisel School of Medicine, USA

Trial

Phase 3, CONQUER

Conference

EAN 2020

9 September, 2020 16:44

Unmet needs and pipeline

Presented By

Prof. Christian Lampl, Headache Medical Center, Austria

Conference

EAN 2020

9 September, 2020 16:39

Multiple Sclerosis

Imaging to evaluate remyelination and neuroprotection

Presented By

Dr Benedetta Bodini, Sorbonne University, France

Conference

EAN 2020

10 September, 2020 13:41

MRI-based clustering of MS patients

Presented By

Dr Raffaello Bonacchi, IRCCS San Raffaele, Italy

Conference

EAN 2020

10 September, 2020 13:29

Serum NfL predicts long-term clinical outcomes in MS

Presented By

Dr Simon Thebault, Ottawa Hospital Research Institute, Canada

Conference

EAN 2020

10 September, 2020 12:39

Epstein-Barr virus-targeted T-cell immunotherapy for progressive MS

Principal Investigator

Prof. Amit Bar-Or, University of Pennsylvania, PA, USA

Conference

EAN 2020

10 September, 2020 12:30

High NEDA rates after 2 years of ocrelizumab

Presented By

Prof. Patrick Vermersch, University of Lille, France

Trial

Phase 3, CASTING

Conference

EAN 2020

10 September, 2020 12:25

Two trials comparing relapsing MS treatments

Presented By

Dr L. Kappos & Dr T. Sprenger

Trial

Phase 3, OPTIMUM, ASCLEPIOS

Conference

EAN 2020

10 September, 2020 12:21

Switching from natalizumab to moderate- versus high-efficacy DMT

Presented By

Dr Carrie M. Hersh, Cleveland Clinic Lerner College of Medicine, OH, USA

Conference

EAN 2020

10 September, 2020 12:17

Results of compounds in late stages of development

Presented By

Dr B.A.C. Cree, Dr D.S. Reich, Dr E. Jasińska

Trial

Phase 3, EVOLVE-MS-1, SPI2

Conference

EAN 2020

10 September, 2020 12:10

Alemtuzumab efficacy and safety data of over 9 years

Presented By

Dr T. Ziemssen, Dr J. Jones, Prof. P. Vermersch

Trial

Phase 3, CARE-MS

Conference

EAN 2020

10 September, 2020 12:07

Fampridine treatment results in routine clinical practice

Presented By

Dr Giovanni Castelnovo, Centre Hospitalier Régional Universitaire de Nîmes, France

Trial

LIBERATE

Conference

EAN 2020

10 September, 2020 12:05

Air pollution is a possible risk factor for MS

Presented By

Prof. Roberto G.E. Bergamasch, IRCCS Mondino Foundation, Italy

Conference

EAN 2020

10 September, 2020 11:31

Neuromyelitis Optica Spectrum Disorder

Genetic association studies in NMOSD needed

Presented By

Dr Viktoria Papp, Aarhus University Hospital, Denmark

Conference

EAN 2020

10 September, 2020 14:08

Eculizumab in NMOSD: the PREVENT study

Presented By

Dr Celia Oreja-Guevara, Hospital Clínico San Carlos, Spain

Trial

Phase 3, PREVENT

Conference

EAN 2020

10 September, 2020 14:03

Long-term safety of satralizumab consistent with double-blind periods

Presented By

Prof. Benjamin Greenberg, University of Texas Southwestern Medical Center, USA

Trial

Phase 3, SAkuraSky; SAkuraStar

Conference

EAN 2020

10 September, 2020 13:58

Neuromuscular Disorders